Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multipl
Khatri BO, Pelletier J, Kappos L, Hartung H-P, Comi G, Barkhof F, von Rosenstiel P, Meng X, Grinspan A, Hashmonay R, et al.
Mult Scler Relat Disord. 2014 May; 3(3):355-63. Epub 2013 Dec 12. PMID: 25876473.Abstract